WO2006123207A3 - A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent - Google Patents

A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent Download PDF

Info

Publication number
WO2006123207A3
WO2006123207A3 PCT/IB2006/000246 IB2006000246W WO2006123207A3 WO 2006123207 A3 WO2006123207 A3 WO 2006123207A3 IB 2006000246 W IB2006000246 W IB 2006000246W WO 2006123207 A3 WO2006123207 A3 WO 2006123207A3
Authority
WO
WIPO (PCT)
Prior art keywords
kit
gastric acid
acid secretion
adjustable amount
inhibiting gastric
Prior art date
Application number
PCT/IB2006/000246
Other languages
French (fr)
Other versions
WO2006123207A2 (en
Inventor
Sabina Glozman
Original Assignee
Vecta Ltd
Sabina Glozman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vecta Ltd, Sabina Glozman filed Critical Vecta Ltd
Publication of WO2006123207A2 publication Critical patent/WO2006123207A2/en
Publication of WO2006123207A3 publication Critical patent/WO2006123207A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Abstract

The present invention relates to an oral kit for inhibiting gastric acid secretion comprising an immediate-release proton pump inhibitor (PPD in conjunction with an adjustable amount of one or more pH regulating agents, e.g., pH regulating agents, and optionally a parietal cell activator or gastric acid stimulant. The present invention further relates to a method of using such kit.
PCT/IB2006/000246 2005-05-20 2006-02-09 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent WO2006123207A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68280805P 2005-05-20 2005-05-20
US60/682,808 2005-05-20

Publications (2)

Publication Number Publication Date
WO2006123207A2 WO2006123207A2 (en) 2006-11-23
WO2006123207A3 true WO2006123207A3 (en) 2007-01-18

Family

ID=37431627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/000246 WO2006123207A2 (en) 2005-05-20 2006-02-09 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent

Country Status (1)

Country Link
WO (1) WO2006123207A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010092467A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022985A1 (en) * 1999-09-28 2001-04-05 The Regents Of The University Of California Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US20040266828A1 (en) * 1999-02-26 2004-12-30 Nitromed, Inc. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US20040266828A1 (en) * 1999-02-26 2004-12-30 Nitromed, Inc. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
WO2001022985A1 (en) * 1999-09-28 2001-04-05 The Regents Of The University Of California Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

Also Published As

Publication number Publication date
WO2006123207A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
WO2005117870A3 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
AU2016204344A1 (en) Improved methods and compositions for wound healing
WO2006020994A3 (en) Compositions and methods using hyaluronic acid and hyluronidase inhibitors
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
MX349787B (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor.
HK1156515A1 (en) Pharmaceutical compositions and methods for accelerating wound healing
WO2006009987A3 (en) Dissolvable film composition
IN2012DN02609A (en)
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
TW200736374A (en) Polishing composition and polishing method
EP1534278A4 (en) Nitrosated proton pump inhibitors, compositions and methods of use
UA97346C2 (en) Stable emulsion composition
MY139088A (en) Sustained release composition of protein drug
WO2007092343A3 (en) Novel epoprostenol formulation and method of making thereof
WO2007079312A3 (en) Compositions and methods for treating actin-mediated medical conditions
WO2007015175A3 (en) Use of pp-1 inhibitors to prevent missplicing events
WO2008015139A3 (en) Inhibitors of zinc proteases thioaryl substituted and their use
WO2007071650A3 (en) Primer composition
UA83203C2 (en) Thiazol-(bi)cycloalkyl-carboxanilides and their use for fighting against undesirable microorganisms
WO2004098599A3 (en) Proton pump inhibitors for the treatment of lower abdominal disorders
WO2006123207A3 (en) A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent
WO2010042685A3 (en) Inhibitors of the atb(0,+) transporter and uses thereof
WO2007098924A3 (en) Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
EP1758569A4 (en) Guanylhydrazone salts, compositions, processes of making and methods of using
WO2005020954A3 (en) Proton pump inhibitor formulations, and methods of preparing and using such formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06710341

Country of ref document: EP

Kind code of ref document: A2